Logo

Empatica's Aura System Receives European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables

Share this

Empatica's Aura System Receives European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables

Shots:

  • Empatica received its CE mark for Aura system as a class lla medical device- along with its remote health monitoring platform (Care) meet safety and performance requirements in the EU
  • Aura system detects and alerts to respiratory infections including COVID-19- before the visible appearance of symptoms. The system has demonstrated a sensitivity of 0.94 in identifying patients with a possible infection in validation studies
  • Aura system collects data from the wearer- including their heart rate- pulse variability and the electrical activity of their skin- to spot the small changes that occur in the body

 ­ Ref: PRNewswire | Image: BioWorld

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions